Belviq

On February 13, 2020, The U.S. Food and Drug Administration (FDA) requested that Japanese pharmaceutical company Eisai remove its weight-loss drugs Belviq and Belviq XR from the market due to findings from a clinical trial showing that long-term use of Belviq was associated with cancer.   The FDA has warned …